The Food and Drug Administration (FDA) has granted traditional approval to Imdelltra ® (tarlatamab-dlle) for the treatment of adults with extensive stage small cell lung cancer (ES-SCLC) with disease ...

Overall survival data showed a 50% reduction in the risk of death with the regimen compared with surgery alone.

In this study, researchers sought to determine the impact of the FDA’s Accelerated Approval pathway among patients with solid tumors.

High rates of vulnerability on a geriatric assessment were identified in a cohort of fit patients aged 60 years or older with acute myeloid leukemia.

(HealthDay News) — For women with a history of breast cancer, real (RA) and sham acupuncture (SA) produce clinically meaningful improvements in perceived cognitive impairment, according to a study ...

Some pediatric patients with low-risk acute myeloid leukemia can receive 4 cycles of chemotherapy, rather than 5, without affecting outcomes.

Following the expanded approval, the accelerated approval for the later-line CLL/SLL was converted to a traditional approval.

The current study assesses whether the MNW could address global disparities in oncology education by reaching low- and middle-income countries and if it was able to advance gender inclusivity in ...

Studies presented at the ASH Annual Meeting 2025 highlighted a novel prognostic approach and emerging treatment strategies in lymphoma.

Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.

In premenopausal women with early breast cancer, survival is not affected by fertility preservation procedures, researchers report.

Man patients with MIBC are ineligible for or refuse SOC cisplatin. SunRISe-4 evaluated neoadjuvant gemcitabine intravesical system (TAR-200) plus cetrelimab or cetrelimab monotherapy for pathologic ...